
Alexion Pharmaceuticals, Inc. ALXN
Alexion Pharmaceuticals, Inc. DPO 2011-2025 | ALXN
DPO Jährlich Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 78.2 | 68.5 | 72.6 | 56.9 | 90.5 | 89.8 | 92.4 | 44.4 | 108 | 62.8 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 108 | 44.4 | 76.4 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.78 | -0.31 % | $ 793 M | ||
|
Aclaris Therapeutics
ACRS
|
887 | $ 3.03 | -0.49 % | $ 234 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 1.15 | -1.71 % | $ 6.27 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Aptevo Therapeutics
APVO
|
239 | $ 0.6 | -35.8 % | $ 166 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 27.09 | 1.04 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 9.6 | 1.27 % | $ 141 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
29.9 | $ 584.81 | -1.07 % | $ 44.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.44 | -3.56 % | $ 15.3 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 92.79 | 0.37 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 12.33 | -0.29 % | $ 812 M | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Celldex Therapeutics
CLDX
|
6.17 K | $ 26.29 | -2.01 % | $ 1.69 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.07 | 2.45 % | $ 716 M | ||
|
Biogen
BIIB
|
65.4 | $ 176.45 | 0.07 % | $ 25.7 B |